The role of LGALS3BP as a suppressor of tumor growth was further substantiated by the finding that a significant tumor regression could be achieved with LGALS3BP injected directly into xenografts originating from LGALS3BP-silenced HCTI16 cells (Fig. 2c). The gene discussed is LGALS3BP; the disease is neoplasm.